Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Date Ascending
Filter
  • 1-10 ل  180 نتائج ل ""deferasirox""

فلترة النتائج

Subject : myelodysplastic syndromes Sort Order : Publication Date Acsending
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

Treating iron overload: New guide tells how.

Subjects: IRON; MYELODYSPLASTIC syndromes; IRON chelatesUNITED StatesUNITED States. Food & Drug Administration

  • Source: Drug Topics; 10/24/2005, Vol. 149 Issue 20, Special section p14-14, 1p

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Periodical

Once-daily tablet treats iron overload.

Subjects: MYELODYSPLASTIC syndromes; BLOOD transfusion; BLOOD diseasesUNITED StatesUNITED States. Food & Drug Administration; NOVARTIS Pharmaceuticals Corp....

  • Source: Drug Topics; 12/12/2005, Vol. 149 Issue 23, p19-19, 1p

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

OncoLog Volume 51, Number 07/08, July/August 2006

Subjects: Issa; Jean-Pierre; Kantarjian

  • Source: OncoLog MD Anderson's Report to Physicians (All issues)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tratamento de suporte e quelação de ferro em pacientes com síndromes mielodisplásicas Supportive care, tranfusion and chelation therapy for patients with myelodysplastic syndromes

Subjects: Síndromes mielodisplásicas; tratamento de suporte; terapia transfusional

  • Source: Revista Brasileira de Hematologia e Hemoterapia, Vol 28, Iss 3, Pp 204-209 (2006)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Periodical

MDS: THERE'S LIGHT AT THE END OF THE TUNNEL.

Subjects: MYELODYSPLASTIC syndromes; BONE marrow diseases; SYNDROMESUNITED StatesUNITED States. Food & Drug Administration

  • Source: Drug Topics; 5/22/2006, Vol. 150 Issue 10, pHSE14-HSE15, 2p

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

SI33 Implications and Management of Iron Overload in Myelodysplastic Syndromes

Subjects: medicine.medical_specialty; Anemia; business.industry

  • Source: Transfusion Medicine. 16:20-20

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade ®, ICL670).

Subjects: *ANEMIA; *MULTIPLE organ failure; *CHELATION therapy

  • Source: European Journal of Haematology. Jun2007, Vol. 78 Issue 6, p540-542. 3p. 1 Chart.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study

Subjects: Myelodysplastic syndromes; Transfusional iron overload; Iron chelator

  • Source: ISSN: 0939-5555.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.

Subjects: Anemia, Diamond-Blackfan/Anemia, Diamond-Blackfan/Anemia, Diamond-Blackfan/*drug therapy ; Benzoates/Benzoates/Benzoates/*therapeutic use ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2008 Feb; Vol. 80 (2), pp. 168-76. Date of Electronic Publication: 2007 Nov 17.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Iron overload in myelodysplastic syndromes

Subjects: Cancer Research; medicine.medical_specialty; Iron Overload

  • Source: Leukemialymphoma. 49(3)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  180 نتائج ل ""deferasirox""